NLRC4 and inflammatory bowel disease: Collectively, our findings establish the NLRC4 V341A KI mouse model as a robust platform for advancing our understanding of AIFEC, VEO-IBD, and related autoinflammatory diseases while providing a basis for developing targeted therapies.